Open Access Highly Accessed Research article

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

Jeffrey L Winters1*, David Brown2, Elisabeth Hazard3, Ashok Chainani3 and Chester Andrzejewski4

Author Affiliations

1 Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First ST SW, Rochester, MN 55905, USA

2 Pharmacy Department, Health New England, One Monarch Place STE 1500, Springfield, MA 01144, USA

3 Pricing & Reimbursement Strategy, ACE Strategic Reimbursement, 909 Jessica Terrace, Downingtown, PA 19335, USA

4 Pathology Department, Baystate Medical Center, 759 Chestnut ST, Springfield, MA 01199, USA

For all author emails, please log on.

BMC Health Services Research 2011, 11:101  doi:10.1186/1472-6963-11-101

Published: 16 May 2011

Additional files

Additional file 1:

The additional data file consists of a spreadsheet (Excel 2003, Microsoft Corporation, Redmond WA) that contains the model used in this manuscript to perform the cost minimization analysis. Individual institutions can input their own direct costs and reimbursement amounts from any specific payer and perform the analysis reported in this study in real-time.

Format: XLSX Size: 24KB Download file

Open Data